Literature DB >> 10605751

Animal testing of retroviral-mediated gene therapy for factor VIII deficiency.

J S Greengard1, D J Jolly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10605751

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  7 in total

Review 1.  Immunomodulation for inhibitors in hemophilia A: the important role of Treg cells.

Authors:  Carol H Miao
Journal:  Expert Rev Hematol       Date:  2010-08       Impact factor: 2.929

Review 2.  Platelet and endothelial expression of clotting factors for the treatment of hemophilia.

Authors:  Robert R Montgomery; Qizhen Shi
Journal:  Thromb Res       Date:  2012-03-14       Impact factor: 3.944

3.  Advances in Overcoming Immune Responses following Hemophilia Gene Therapy.

Authors:  Carol H Miao
Journal:  J Genet Syndr Gene Ther       Date:  2011-12-23

4.  Advancements in gene transfer-based therapy for hemophilia A.

Authors:  Christopher B Doering; H Trent Spencer
Journal:  Expert Rev Hematol       Date:  2009-12       Impact factor: 2.929

5.  Persistent expression of factor VIII in vivo following nonprimate lentiviral gene transfer.

Authors:  Yubin Kang; Litao Xie; Diane Thi Tran; Colleen S Stein; Melissa Hickey; Beverly L Davidson; Paul B McCray
Journal:  Blood       Date:  2005-05-10       Impact factor: 22.113

6.  Transient blockade of the inducible costimulator pathway generates long-term tolerance to factor VIII after nonviral gene transfer into hemophilia A mice.

Authors:  Baowei Peng; Peiqing Ye; Bruce R Blazar; Gordon J Freeman; David J Rawlings; Hans D Ochs; Carol H Miao
Journal:  Blood       Date:  2008-06-23       Impact factor: 22.113

Review 7.  Gene therapy for haemophilia.

Authors:  Samuel L Murphy; Katherine A High
Journal:  Br J Haematol       Date:  2008-03       Impact factor: 6.998
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.